Overexpression of miR-217 reduces IL-6 levels, which in turn inhibits the JAK2/STAT3 pathway, decreasing M2 macrophage markers and promoting an immune environment less conducive to tumor progression. This evidence concerns the gene IL6 and neoplasm.